Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pharma-Bio Serv (PBSV) Return on Invested Capital (2016 - 2026)

Pharma-Bio Serv's Return on Invested Capital history spans 14 years, with the latest figure at 0.07% for Q1 2026.

  • For Q1 2026, Return on Invested Capital changed 0.0% year-over-year to 0.07%; the TTM value through Jan 2026 reached 0.07%, changed 0.0%, while the annual FY2025 figure was 0.05%, 4.0% up from the prior year.
  • Return on Invested Capital reached 0.07% in Q1 2026 per PBSV's latest filing, down from 0.06% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.07% in Q3 2023 to a low of 0.25% in Q2 2022.
  • Average Return on Invested Capital over 5 years is 0.05%, with a median of 0.06% recorded in 2025.
  • Peak YoY movement for Return on Invested Capital: plummeted -31bps in 2022, then soared 31bps in 2023.
  • A 5-year view of Return on Invested Capital shows it stood at 0.06% in 2022, then decreased by -12bps to 0.05% in 2023, then tumbled by -280bps to 0.1% in 2024, then skyrocketed by 35bps to 0.06% in 2025, then fell by -18bps to 0.07% in 2026.
  • Per Business Quant, the three most recent readings for PBSV's Return on Invested Capital are 0.07% (Q1 2026), 0.06% (Q4 2025), and 0.05% (Q3 2025).